Lee-JahChangMD

Internal Medicine • Gaithersburg, MD

Allergy & Immunology

Director, Global Clinical Development

Join to view full profile

Dr. Chang is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Chang's full profile

Already have an account?

Office
1 Medimmune Way
Gaithersburg, MD 20878
Phone+1 301-398-0000

Fax+1 570-957-0934

Education & Training

National Institutes of Health Clinical CenterFellowship, Allergy and Immunology, 2010 - 2013
McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 2007 - 2010
Northwestern University The Feinberg School of MedicineClass of 2007

Certifications & Licensure

MD State Medical License 2011 - 2026
VA State Medical License 2011 - 2026
PA State Medical License 2013 - 2024
IL State Medical License 2007 - 2017
American Board of Allergy and Immunology Allergy & Immunology

Clinical Trials

Study of Investigational Pneumococcal Vaccine in Healthy Adults, Toddlers and Infants Start of enrollment: 2011 Sep 01
Completed
Phase 1
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents Start of enrollment: 2014 Jul 22
Completed
Phase 2
Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Patients ≥65 Years Start of enrollment: 2017 Sep 15
Completed
Phase 1, Phase 2
Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Participants ≥65 Years in the US Start of enrollment: 2017 Sep 08
Completed
Phase 3
Safety and Immunogenicity of Different Dosages of High-Dose Quadrivalent Influenza Vaccine in Children 6 Months to 17 Years of Age Start of enrollment: 2018 Oct 09
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

2 citations
Superior immunogenicity of high-dose quadrivalent inactivated influenza vaccine versus Standard-Dose vaccine in Japanese Adults ≥ 60 years of age: Results from a phase...
Leilani Sanchez, Takahiro Nakama, Hideaki Nagai, Osamu Matsuoka, Satoshi Inoue
Vaccine. 2023-04-06
2 citations
Safety and immunogenicity of high doses of quadrivalent influenza vaccine in children 6 months through <18 years of age: A randomized controlled phase II dose-finding ...
Lee-Jah Chang, Evan J. Anderson, Robert Jeanfreau, Ying He, Bryony Hicks
Vaccine. 2021-02-18
8 citations
Introductory paper: High-dose influenza vaccine
Mia Diaco, Lee-Jah Chang, Bruce T. Seet, Corey A Robertson, Ayman Chit
Vaccine. 2021-02-03